Fairfax Financial Holdings’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Fairfax Financial Holdings’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-42,000	Closed	-$2.02M	–	64
2020 Q1	$2.02M	Buy	+42,000	New	+$1.95M	0.14%	23

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Fairfax Financial Holdings's RARX Position: Q2 2020 in Review

Fairfax Financial Holdings sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 42,000 shares — an estimated $2.02M sold.

Fairfax Financial Holdings first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $2.02M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Fairfax Financial Holdings reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Fairfax Financial Holdings sold 42,000 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $2.02M.
Fairfax Financial Holdings first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Fairfax Financial Holdings's Ra Pharmaceuticals, Inc. Common Stock position peaked at $2.02M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Fairfax Financial Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.